From: Promoting Independence in Dementia (PRIDE): protocol for a feasibility randomised controlled trial
Months | 0 | 0–2 | 3 | 6f | |
Study Procedures and Assessments: Participants | Visit 1 | RANDOMISATION | Intervention period | Visit 2 | Visit 3 |
Baseline | Follow-up | ||||
 Initial eligibility screena | X | Intervention: PRIDE intervention (3 sessions with a PRIDE facilitator) in addition to usual care Control: Usual care only |  |  | |
 Informed consentb | X |  |  | ||
 Demographic information | X |  |  | ||
 Post-consent eligibility screen: Clinical Dementia Rating (CDR) Scalec | X |  |  | ||
 Lawton IADL Scale | X | X | X | ||
 EuroQoL Quality of Life (EQ-5D-5 L) | X | X | X | ||
 DEMQOL | X | X | X | ||
 Geriatric Depression Scale (GDS) | X | X | X | ||
 Standardised Mini Mental State Exam (SMMSE) | X | X | X | ||
 Control, Autonomy, Self-realisation and Pleasure (CASP-19) | X | X | X | ||
 Impact on Participation and Autonomy (IPAQ-O) – Social Relations Sub-Scale | X | X | X | ||
 Positive Psychology Outcome Measure (PPOM) | X | X | X | ||
 Social Engagement Checklist | X | X | X | ||
 Global Change Measure |  | X | X | ||
 Client Service Receipt Inventory (CSRI) | X | X | X | ||
 Focus groups with facilitators and participants / supporters |  | Xd |  | ||
Study Procedures and Assessments: Supporters | Visit 1 | Visit 2 | Visit 3f | ||
Baseline | Follow-up | ||||
 Informed consent | X |  |  | ||
 Supporter questionnaire: EuroQoL Quality of Life (EQ-5D-5 L)e | X | X | X | ||
 Global Change Measuree |  | X | X | ||
 Supporter questionnaire: Client Service Receipt Inventory (CSRI)e | X | X | X |